MMYT vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MMYT exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. However, there is a severe valuation disconnect, as the current price of $44.62 trades at a massive premium to the growth-based intrinsic value of $3.64 and shows a negative Price/Book ratio. While the Forward P/E of 20.95 suggests a significant earnings recovery is expected, the technical trend remains bearish following a 54.5% one-year decline. The stock is currently a battle between strong fundamental health/analyst optimism and poor valuation/price momentum.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
MMYT vs TSLA: Head-to-Head Comparison
This page compares MakeMyTrip Limited (MMYT) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.